MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$51,989,000
EPS
-$11.25
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Research and development expenses
440,000
432,530
521,069
732,315
General and administrative expenses
5,400,000
1,568,951
1,243,009
1,150,397
Acquired in process research and development
-46,185,000
-
-
-
Total operating expenses
52,025,000
2,001,481
1,764,078
1,882,712
Loss from operations
-52,025,000
-2,001,481
-1,764,078
-1,882,712
Other income (expenses)
-
-
-513
-861
Interest income
58,000
47,059
47,860
23,747
Change in fair value of milestone warrant rights liability
-8,280,000
-
-
-
Financing expense related to milestone warrant rights liability
2,067,000
-
-
-
Loss on extinguishment
-6,054,000
-
-
-
Loss on equity method investment
-181,000
-67,970
-76,920
-98,730
Inducement expense
-
-
-
0
Total other income (expense)
36,000
-20,911
-29,573
-75,844
Net loss
-51,989,000
-2,022,392
-1,793,651
-1,958,556
Basic EPS
-11.25
-1.48
-0.08
-0.18
Diluted EPS
-11.25
-1.48
-0.08
-0.18
Basic Average Shares
4,621,735
1,370,109
22,171,309
-
Diluted Average Shares
4,621,735
1,370,109
22,171,309
10,622,720
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
milestone warrant rights...
-$8,280,000
Interest income
$58,000
(144.24%↑ Y/Y)
Net loss
-$51,989,000
(-2554.46%↓ Y/Y)
Total other income
(expense)
$36,000
(147.47%↑ Y/Y)
Loss on
extinguishment
-$6,054,000
Financing expense related
to milestone...
$2,067,000
Loss on equity method
investment
-$181,000
(-83.33%↓ Y/Y)
Loss from operations
-$52,025,000
(-2663.30%↓ Y/Y)
Total operating
expenses
$52,025,000
(2663.30%↑ Y/Y)
Acquired in process
research and development
-$46,185,000
General and
administrative expenses
$5,400,000
(369.40%↑ Y/Y)
Research and development
expenses
$440,000
(-39.92%↓ Y/Y)
Buy us a coffee
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)